BeiGene (FRA:49BA) Days Payable : 286.44 (As of Dec. 2023)

View and export this data going back to 2016. Start your Free Trial

What is BeiGene Days Payable?

BeiGene's average Accounts Payable for the three months ended in Dec. 2023 was €305 Mil. BeiGene's Cost of Goods Sold for the three months ended in Dec. 2023 was €97 Mil. Hence, BeiGene's Days Payable for the three months ended in Dec. 2023 was 286.44.

The historical rank and industry rank for BeiGene's Days Payable or its related term are showing as below:

FRA:49BA' s Days Payable Range Over the Past 10 Years
Min: 40.55 Med: 575.76 Max: 2998.96
Current: 280.55

During the past 11 years, BeiGene's highest Days Payable was 2998.96. The lowest was 40.55. And the median was 575.76.

FRA:49BA's Days Payable is ranked better than
65.97% of 714 companies
in the Biotechnology industry
Industry Median: 148.12 vs FRA:49BA: 280.55

BeiGene's Days Payable declined from Dec. 2022 (350.29) to Dec. 2023 (286.44). It may suggest that BeiGene accelerated paying its suppliers.

BeiGene Days Payable Historical Data

The historical data trend for BeiGene's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BeiGene Days Payable Chart

BeiGene Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Payable

Get a 7-Day Free Trial

597.64

945.52

528.83

344.51

297.14

BeiGene Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Days Payable	Get a 7-Day Free Trial															350.29	300.84	242.98	286.53	286.44

Competitive Comparison of BeiGene's Days Payable

For the Biotechnology subindustry, BeiGene's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BeiGene's Days Payable Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BeiGene's Days Payable distribution charts can be found below:

* The bar in red indicates where BeiGene's Days Payable falls into.

BeiGene Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

BeiGene's Days Payable for the fiscal year that ended in Dec. 2023 is calculated as

	Days Payable (A: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2022 )	+	Accounts Payable (A: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2023 )	*	Days in Period
=	( (278.273	+	288.957)	/	2 )	/	348.386	*	365
=	283.615					/	348.386	*	365
=	297.14

BeiGene's Days Payable for the quarter that ended in Dec. 2023 is calculated as:

	Days Payable (Q: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Sep. 2023 )	+	Accounts Payable (Q: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (Q: Dec. 2023 )	*	Days in Period
=	( (320.32	+	288.957)	/	2 )	/	97.048	*	365 / 4
=	304.6385					/	97.048	*	365 / 4
=	286.44

BeiGene Days Payable Related Terms

Thank you for viewing the detailed overview of BeiGene's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

BeiGene (FRA:49BA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BeiGene Ltd (FRA:49BA) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

BGNE:USA 06160:Hong Kong 49BA:Germany 688235:China B1GN34:Brazil

Address

c/o Mourant Governance Services (Cayman) Limited, 94 Solaris Avenue, Camana Bay, Grand Cayman, CYM, KY1-1108

Website

https://www.beigene.com

BeiGene Ltd is a commercial-stage biotechnology company. It is engaged in the discovery and development of molecularly targeted and immuno-oncology drugs for the treatment of cancer. The company has developed a proprietary cancer biology platform that addresses the importance of tumor-immune system interactions and the value of primary biopsies in developing new models to support its drug discovery effort. It has developed clinical-stage drug candidates that inhibit the important oncology targets Bruton's tyrosine kinase, or BTK; RAF dimer protein complex and PARP family of proteins, and an immuno-oncology agent that inhibits the immune checkpoint protein receptor PD-1. Its geographical segments are China, the United States, and the Rest of the world.

BeiGene (FRA:49BA) Headlines

No Headlines